Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Medical Genetics · Morquio Syndrome

What Is the Life Expectancy for Morquio Syndrome (MPS IV)?

At a Glance

The life expectancy for Morquio syndrome (MPS IV) has significantly increased due to modern treatments like Enzyme Replacement Therapy and proactive spinal surgeries. While historically averaging 25 years, many individuals now live well into adulthood, reaching their 50s and 60s.

The life expectancy for someone living with Morquio syndrome (MPS IV) today is significantly higher than it was in the past. While historical data often cited a shorter lifespan, modern treatments, proactive surgeries, and multidisciplinary care are helping many individuals with MPS IV live well into adulthood and their senior years [1][2].

Because Morquio syndrome is a progressive condition with a wide spectrum of severity—ranging from severe to more attenuated (milder) forms—the outlook for each person is highly individualized. Life expectancy and quality of life depend heavily on the severity of symptoms and how early specialized care is received.

Historical Perspectives vs. Modern Outcomes

In the past, the mean age of death for individuals with Morquio syndrome was around 25 years of age [1]. This was largely due to severe, untreated complications like respiratory failure (the inability of the lungs to provide enough oxygen) [3] and spinal cord compression caused by cervical instability (looseness in the neck bones) [4].

Today, these historical numbers significantly underestimate how long a person diagnosed with MPS IV can expect to live [1]. With the introduction of modern medical standards, life expectancy is increasing [1]. There are documented cases of patients successfully undergoing surgical procedures in their 50s and 60s, showing that individuals with Morquio syndrome are increasingly reaching older adulthood [2][5].

Factors Improving Life Expectancy Today

The increase in life expectancy for people with MPS IV is due to several critical medical advancements:

  • Enzyme Replacement Therapy (ERT): For individuals with Morquio A (MPS IVA), medications like elosulfase alfa provide the specific enzyme the body is missing. This treatment, typically given as a weekly intravenous (IV) infusion, has been shown to stabilize or improve endurance, breathing, and the ability to perform daily activities [6][7]. (Note: ERT is currently only available for type IVA, not type IVB).
  • Advanced Spinal Surgeries: A major risk in Morquio syndrome is damage to the spinal cord in the neck. Proactive procedures like cervical spinal fusion (permanently joining the neck bones to stabilize them) can prevent severe neurological complications and improve survival [8][9].
  • Multidisciplinary Monitoring: Because MPS IV affects many body systems, patients are living longer by being closely followed by a dedicated team of specialists. This team typically includes a geneticist, pulmonologist (lung specialist), cardiologist (heart specialist), and orthopedic surgeon (bone specialist). Together, they can catch and treat issues like restrictive lung disease, sleep apnea, and heart valve problems before they become life-threatening [10][11].
  • Safer Surgical and Airway Management: Individuals with Morquio syndrome face high risks during anesthesia due to their unique airway anatomy and potential heart issues [12]. Improved techniques and specialized surgical teams familiar with the disorder have made operations much safer [13].

Looking Forward and Quality of Life

Living well into adulthood requires lifelong, proactive medical care. While living longer is an important milestone, actively managing daily quality of life—such as addressing chronic pain, preserving joint mobility, and ensuring independence—is equally crucial.

Routine monitoring is essential to catching complications early [11]. A comprehensive care plan should include regular check-ups such as:

  • Breathing tests to monitor lung function
  • Sleep studies (polysomnography) to check for sleep apnea
  • Echocardiograms to monitor heart valve health
  • Spinal imaging (MRI or X-rays) to assess neck stability

While challenges remain, individuals newly diagnosed with Morquio syndrome and their families can find hope in knowing that the medical landscape has transformed, offering the opportunity to live longer, more fulfilling lives.

Common questions in this guide

What is the average life expectancy for someone with Morquio syndrome?
While historically the average life expectancy was around 25 years, modern medical care has significantly improved outcomes. Today, many individuals with Morquio syndrome live well into their 50s, 60s, and beyond, depending on the severity of their condition and access to care.
What treatments have improved the lifespan for people with MPS IV?
Advancements like Enzyme Replacement Therapy (ERT) for Type IVA, proactive cervical spinal surgeries, and careful airway management during anesthesia are key. These treatments protect the spinal cord, manage breathing issues, and support daily organ function.
Why do patients with Morquio syndrome need multiple specialists?
MPS IV affects multiple body systems, requiring a comprehensive team approach. Routine monitoring by specialists like pulmonologists, cardiologists, and orthopedic surgeons helps catch and treat lung disease, heart valve problems, and spinal instability before they become severe.
Is enzyme replacement therapy available for all types of Morquio syndrome?
No, enzyme replacement therapy medications like elosulfase alfa are currently only available for individuals with Morquio A (MPS IVA). This treatment replaces the specific missing enzyme for that subtype and is not used for type IVB.
What routine tests are needed to monitor Morquio syndrome complications?
You will likely need regular breathing tests to monitor lung function, sleep studies to check for sleep apnea, echocardiograms for heart valve health, and spinal imaging like MRIs to assess neck stability. Your doctor will determine the right schedule based on your symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my specific symptoms, where do we fall on the spectrum of severity, and how might that affect my long-term outlook?
  2. 2.Which specific specialists (like a pulmonologist or cardiologist) do we need to add to our care team right now to ensure we are monitoring all major risk factors?
  3. 3.What specific precautions will the surgical and anesthesia teams take for my airway management during any future procedures?
  4. 4.Is enzyme replacement therapy (elosulfase alfa) appropriate and available for my specific subtype of Morquio syndrome?
  5. 5.How often should I be getting comprehensive evaluations, such as sleep studies and spinal MRIs, to catch potential complications early?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Does Morquio Syndrome (MPS IV) Affect Intelligence?How Effective Is Vimizim for Morquio Syndrome?How Rare is Morquio Syndrome (MPS IV)? Prevalence StatsHow Do I Transition to Adult Care for Morquio Syndrome?What Are Common Orthopedic Surgeries for Morquio?What Are the Dental Problems in Morquio Syndrome (MPS IV)?Signs of Spinal Compression in Morquio Syndrome?What Does a VUS Result Mean in Morquio Syndrome Testing?What to Put in a Morquio Syndrome Emergency LetterMorquio Type A vs. Type B: What is the Difference?What Is the Inheritance Pattern of Morquio Syndrome?Why Are ENT Procedures Common in Morquio Syndrome?Why is Anesthesia High-Risk for Morquio Syndrome?

References

References (13)
  1. 1

    Understanding bias when estimating life expectancy from age at death: a simulation approach applied to Morquio syndrome A.

    Yin X, Ahn J, Boca SM

    BMC research notes 2022; (15(1)):19 doi:10.1186/s13104-021-05894-0.

    PMID: 35033196
  2. 2

    TAVI-in-TAVI in a patient with morquio syndrome: a case report.

    Chin DXL, De Michele G, Cristofani D, De Felice F

    European heart journal. Case reports 2026; (10(1)):ytaf662 doi:10.1093/ehjcr/ytaf662.

    PMID: 41561774
  3. 3

    Causes of death in mucopolysaccharidoses.

    Rintz E, Banacki M, Ziemian M, et al.

    Molecular genetics and metabolism 2024; (142(3)):108507 doi:10.1016/j.ymgme.2024.108507.

    PMID: 38815294
  4. 4

    Air- Q intubating laryngeal airway guided intubation in Morquio syndrome.

    Mohammed S, Gupta SK, Bhatia PK, et al.

    Indian journal of anaesthesia 2018; (62(6)):473-474 doi:10.4103/ija.IJA_465_17.

    PMID: 29962532
  5. 5

    Adult Morquio syndrome requiring occipito-thoracic fusion.

    Okumura R, Hasegawa K, Tsuge S, et al.

    Journal of orthopaedic surgery (Hong Kong) 2020; (28(2)):2309499020918424 doi:10.1177/2309499020918424.

    PMID: 32329403
  6. 6

    Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time.

    Burton BK, Stepien KM, Campeau PM, et al.

    Genetics in medicine open 2025; (3()):103428 doi:10.1016/j.gimo.2025.103428.

    PMID: 40677308
  7. 7

    Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England.

    Cleary M, Davison J, Gould R, et al.

    Orphanet journal of rare diseases 2021; (16(1)):38 doi:10.1186/s13023-021-01675-x.

    PMID: 33478511
  8. 8

    Atlantoaxial instability treated with free-hand C1-C2 fusion in a child with Morquio syndrome.

    Moon E, Lee S, Chong S, Park JH

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020; (36(8)):1785-1789 doi:10.1007/s00381-020-04561-2.

    PMID: 32172394
  9. 9

    An Evidence-based Approach to the Management of Children With Morquio A Syndrome Presenting With Craniocervical Pathology.

    Williams N, Narducci A, Eastwood DM, et al.

    Spine 2018; (43(24)):E1443-E1453 doi:10.1097/BRS.0000000000002743.

    PMID: 29901537
  10. 10

    [Mucopolysaccharidosis: clinical features, diagnosis and management].

    Suarez-Guerrero JL, Gómez Higuera PJ, Arias Flórez JS, Contreras-García GA

    Revista chilena de pediatria 2016; (87(4)):295-304.

    PMID: 26613630
  11. 11

    Evaluation of sleep-disordered breathing and its relationship with respiratory parameters in children with mucopolysaccharidosis Type IVA and VI.

    Ademhan Tural D, Emiralioglu N, Dogru D, et al.

    American journal of medical genetics. Part A 2021; (185(8)):2306-2314 doi:10.1002/ajmg.a.62229.

    PMID: 33960649
  12. 12

    Total Hip Arthroplasty in a Patient with Mucopolysaccharidosis Type IVB.

    van den Eeden YNT, Unter Ecker N, Kleinertz H, et al.

    Case reports in orthopedics 2021; (2021()):5584408 doi:10.1155/2021/5584408.

    PMID: 34012686
  13. 13

    Coordinated approach to spinal and tracheal reconstruction in a patient with morquio syndrome.

    Kiessling P, Stans AA, Dearani JA, et al.

    International journal of pediatric otorhinolaryngology 2020; (128()):109721 doi:10.1016/j.ijporl.2019.109721.

    PMID: 31639621

This page provides general information about life expectancy and outcomes for Morquio syndrome. It does not replace personalized medical advice or prognostic evaluations from your geneticist or healthcare team.

Get notified when new evidence is published on Mucopolysaccharidosis type 4.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.